Crispr Therapeutics shares tumble after significant earnings miss
LONDON - J.P. Morgan SE announced today that it has not undertaken any stabilization activities for the Abertis Infraestructuras Finance B.V. securities offering. Following the pre-stabilization announcement on May 14, 2025, the firm disclosed that no market actions were required to stabilize the EUR 500 million perpetual non-call 5.75-year hybrid bond (HYRBID), listed on the Euronext (EPA:ENX) Dublin Stock Exchange.
Stabilization measures are typically executed by underwriters to support the market price of a security after its initial offering. However, in this instance, J.P. Morgan SE, acting as the stabilization coordinator, along with Bofa Securities as the stabilization manager, confirmed that such interventions were not necessary.
The offer price for the bond was set at 100.000%, and due to the absence of stabilization activities, it suggests that the market conditions and investor demand were sufficient to maintain the bond’s price stability post-launch.
The announcement serves as a routine regulatory disclosure, indicating compliance with the Market Abuse Regulation (EU/596/2014) and Financial Conduct Authority rules. It is also a standard procedure to inform market participants about the completion of the post-stabilization period.
This information, originally disseminated by RNS, the news service of the London Stock Exchange (LON:LSEG), is based on a press release statement and is intended for informational purposes. It does not constitute an offer to sell or a solicitation of an offer to buy the securities mentioned.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.